Statistics about Health, Pharma & Medtech in United States
Statistics
- Safety and independence due to hearing aids in select developed countries 2014-2015
- Yearly cost savings using 3D-printed guides in surgery 2019, by specialty
- Relationship improvement due to hearing aids in select developed countries 2014-2015
- Annual change in U.S. hearing aid sales 2007-2022
- U.S. adults with hearing trouble who had used a hearing aid 2014, by age
- Preferred methods of choice for sharing wearable health data in the U.S. 2023
- Elderly adults in the U.S. with a mobility aid who had fallen 2015, by insurance
- Value of medical device imports from the U.S. to Taiwan 2014-2019
- Injuries from crutches, canes and walkers in the U.S 2002-2010
- Injuries from crutches, canes and walkers in the U.S in 2010, by body part injured
- Likelihood of choosing a doctor who uses wearable data in the U.S. 2023
- Injuries from crutches, canes and walkers in the U.S in 2010, by diagnosis
- Improved life quality due to hearing aids in select developed countries 2014-2015
- Elderly adults in the U.S. with a mobility aid who had fallen 2015, by age
- Possible time saved using 3D-printed guides in surgery 2019
- Reasons for nonuse among elderly adults in the U.S. with a mobility aid 2015
- Most prescribed hearing aid brands or manufacturers among U.S. audiologists 2018
- Possible cost savings using 3D-printed guides in surgery 2019
- Yearly time savings using 3D-printed guides in surgery 2019, by specialty
- Types of chatbots used in medical practices in the U.S. in 2023
- Reasons for sharing data from personal devices with doctors in the U.S. 2023
- Main medical chatbot applications for patients in the U.S. in 2023
- Doctors' trust in chatbots' abilities in the U.S. in 2023
- U.S. top prescribed drugs based on sales 2022
- Job and income satisfaction among U.S. biotech sales representatives 2018
- Alliances U.S. and Europe biotech companies by total potential value 2022
- CBD market size distributed by pharmacies and practitioners in the U.S. 2019-2026
- U.S. academic bioscience research and development expenditure by field
- COVID-19 vaccinations administered in the U.S. as of April 2023, by manufacturer
- U.S. biological product manufacturing gross output 1998-2016
- U.S. adults that had genetic testing for cancer risk as of 2018
- Gross profit margin of select U.S. biotech and drugs companies Q3 2023
- CBD pharmaceuticals market size in the United States 2019-2026
- Cell-free DNA based cancer diagnostic and screening market US vs. world 2020
- Medical cannabis market size in the United States by type 2019 and 2025
- U.S. adults that used commercial genetic testing for select reasons 2018
- U.S. biotech companies market capitalization 1994-2016
- Biotech market cap change since flotation in U.S. companies 2019
- Opinion on drug spending reduction due to biosimilars for specialty drugs 2017-2020
- Number of FDA approvals for CAR-T cell therapies 2012-2024
- Largest biotech financing deals in the United States in Q4 2020, by company
- U.S. and Europe's selected anti-CD19 Car-T therapy sales forecast 2024
- Share of capital allocation among big biotechs in U.S. and Europe by type 2014-2019
- Disparities median price Lantus by select countries 2019
- Biosimilars in development and approved by FDA 2019, by manufacturer
- Influences for likely seeking future genetic testing in the U.S. 2018, by test type
- Regeneron Pharmaceuticals top product net sales 2020-2023
- Cumulative number of drugs with biosimilars approved US and Europe 2006-2018
- Biotech vs. Web 2.0 share of total U.S. venture investment 2005-2010
- Top drugs advertised to consumers in the U.S. in 2018, by total DTCA spending
- Biotech industry 2010: comparison of the US and Europe
- Commercial leaders vs. other companies in U.S. biotech 2016
- Influences for seeking genetic testing among U.S. adults in 2018, by test type
- Likelihood for future genetic testing use in U.S. adults in 2018, by type
- biotechnology funding by National Institutes for Health 2013-2025
- Opinions on the importance of vaccines according to U.S. adults 2018 vs 2020
- Sales per employee of select U.S. biotech and drugs companies Q3 2023
- Comparison WAC of Herceptin vs biosimilars in the U.S. Q2 2020
- U.S. average annual wages per employee by industry 2021
- U.S. bioscience venture capital investments 2009-2021
- U.S. states with large employment in drugs and pharmaceuticals 2021
- U.S. metropolitan areas by employment in research and medical laboratories 2021
- Top U.S. states based on academic bioscience R&D expenditure 2020
- U.S. bioscience-related patents by segment 2018-2021
- Comparison WAC of Remicade vs biosimilars in the U.S. as of Q3 2020
- Comparison ASP Herceptin vs biosimilars in the U.S. Q2 2020
- Number of biosimilar drugs becoming available United States 2015-2022
- U.S. bioscience employment distribution 2021 by subsector
- U.S. specialists and familiarity with biosimilars 2021
- Biosimilars approved for marketing Europe vs U.S. 2022 by year since approval
- Total stem cell research funding by the National Institutes for Health 2013-2025
- Top companies based on CAR-T cancer therapy patents 2010-2021
- Physician office payment for biosimilars in Medicare Part B 2022
- Price increase of select biotech drugs in the U.S. during January 2021
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Total genetics funding by National Institutes for Health 2013-2025
- U.S. biotech industry revenues
- U.S. bioscience employment by subsector 2021
- Number of biotech companies in the U.S. 2012-2016
- CAGR of the biosimilars market in Europe and the United States 2018-2025
- Number of discovered genes with known disease-causing mutations 2003 and 2015
- U.S. bioscience industry revenue by subsector
- Potential biosimilars savings in EU5 countries and the U.S. 2016-2020
- U.S. bioscience-related patents number 2009-2021
- U.S. adults that believed they personally benefited from vaccines 2018
- mRNA vaccine and therapy market value U.S. 2020-2030
- U.S. biotech industry R&D expense
- Expected top life science startups in the U.S. 2024
- Pharma and biotech - average p/e ratios in 2005 and 2010
- U.S. bioscience employment totals 2018-2021
- BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Total raised capital in U.S. and Europe biotechnology industry 2015-2022
- First biosimilar marketing initiatives by MCOs in U.S. 2015
- Select COVID-19 vaccine pricing and funding as of August 2020
- Projection of top 2024 pharma and biotech launches by revenue 2028
- Comparison ASP of Remicade vs biosimilars in the U.S. Q3 2020
- U.S. bioscience establishments totals 2018-2021
- Number of U.S. bioscience establishments by subsectors 2021
- Humira U.S. price change 2021-2022
- YTD stock performance of biopharma companies working on COVID March 2020